Fig. 2From: Switching from entecavir to tenofovir disoproxil fumarate for HBeAg-positive chronic hepatitis B patients: a phase 4, prospective studyMean change in HBsAg up to week 96 (FAS). FAS, full analysis set; HBsAg, hepatitis B surface antigenBack to article page